PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jclinpathJournal of Clinical PathologyVisit this articleSubmit a manuscriptReceive email alertsContact usBMJ
 
J Clin Pathol. 1990 March; 43(3): 213–219.
PMCID: PMC502333

Ber-EP4: new monoclonal antibody which distinguishes epithelia from mesothelial.

Abstract

A new monoclonal antibody, Ber-EP4, directed against a partially formol resistant epitope on the protein moiety of two 34 kilodalton and 39 kilodalton glycopolypeptides on human epithelial cells is described. Immunostaining of a wide range of normal and neoplastic human tissues and cell lines showed that all carcinomas and all non-neoplastic epithelial cells, except hepatocytes, parietal cells, and apical cell layers in squamous epithelia, homogeneously expressed Ber-EP4 antigen. As Ber-EP4 does not detect any normal or neoplastic non-epithelial cells, this antibody might prove valuable for the differentiation of the following (i) non-epithelial tumours from undifferentiated carcinomas; (ii) hepatocytes from bile duct cells in certain liver diseases; (iii) mesothelial cells from carcinoma cells in lung biopsy specimens; and (iv) reactive mesothelial cells from carcinoma cells in smears of serous effusions.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (2.2M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Gatter KC, Alcock C, Heryet A, Mason DY. Clinical importance of analysing malignant tumours of uncertain origin with immunohistological techniques. Lancet. 1985 Jun 8;1(8441):1302–1305. [PubMed]
  • Damjanov I, Knowles BB. Biology of disease. Monoclonal antibodies and tumor-associated antigens. Lab Invest. 1983 May;48(5):510–525. [PubMed]
  • Gatter KC, Abdulaziz Z, Beverley P, Corvalan JR, Ford C, Lane EB, Mota M, Nash JR, Pulford K, Stein H, et al. Use of monoclonal antibodies for the histopathological diagnosis of human malignancy. J Clin Pathol. 1982 Nov;35(11):1253–1267. [PMC free article] [PubMed]
  • Lauder I, Holland D, Mason DY, Gowland G, Cunliffe WJ. Identification of large cell undifferentiated tumours in lymph nodes using leucocyte common and keratin antibodies. Histopathology. 1984 Mar;8(2):259–272. [PubMed]
  • Cooper D, Schermer A, Sun TT. Classification of human epithelia and their neoplasms using monoclonal antibodies to keratins: strategies, applications, and limitations. Lab Invest. 1985 Mar;52(3):243–256. [PubMed]
  • Osborn M, Weber K. Tumor diagnosis by intermediate filament typing: a novel tool for surgical pathology. Lab Invest. 1983 Apr;48(4):372–394. [PubMed]
  • Kasper M, Karsten U. Coexpression of cytokeratin and vimentin in Rathke's cysts of the human pituitary gland. Cell Tissue Res. 1988 Aug;253(2):419–424. [PubMed]
  • Gröne HJ, Weber K, Gröne E, Helmchen U, Osborn M. Coexpression of keratin and vimentin in damaged and regenerating tubular epithelia of the kidney. Am J Pathol. 1987 Oct;129(1):1–8. [PubMed]
  • Henzen-Logmans SC, Mullink H, Ramaekers FC, Tadema T, Meijer CJ. Expression of cytokeratins and vimentin in epithelial cells of normal and pathologic thyroid tissue. Virchows Arch A Pathol Anat Histopathol. 1987;410(4):347–354. [PubMed]
  • Domagala W, Weber K, Osborn M. Diagnostic significance of coexpression of intermediate filaments in fine needle aspirates of human tumors. Acta Cytol. 1988 Jan-Feb;32(1):49–59. [PubMed]
  • Milani S, Herbst H, Schuppan D, Niedobitek G, Kim KY, Stein H. Vimentin expression of newly formed rat bile duct epithelial cells in secondary biliary fibrosis. Virchows Arch A Pathol Anat Histopathol. 1989;415(3):237–242. [PubMed]
  • Wagener C, Breuer H. Biochemical and immunochemical aspects of carcinoembryonic antigen (CEA) and CEA related antigens: current status and future perspectives. J Clin Chem Clin Biochem. 1982 Oct;20(10):705–712. [PubMed]
  • Cordell J, Richardson TC, Pulford KA, Ghosh AK, Gatter KC, Heyderman E, Mason DY. Production of monoclonal antibodies against human epithelial membrane antigen for use in diagnostic immunocytochemistry. Br J Cancer. 1985 Sep;52(3):347–354. [PubMed]
  • Edwards PA. Heterogeneous expression of cell-surface antigens in normal epithelia and their tumours, revealed by monoclonal antibodies. Br J Cancer. 1985 Feb;51(2):149–160. [PubMed]
  • Daffos F, Forestier F, Grangeot-Keros L, Capella Pavlovsky M, Lebon P, Chartier M, Pillot J. Prenatal diagnosis of congenital rubella. Lancet. 1984 Jul 7;2(8393):1–3. [PubMed]
  • Ghosh AK, Gatter KC, Dunnill MS, Mason DY. Immunohistological staining of reactive mesothelium, mesothelioma, and lung carcinoma with a panel of monoclonal antibodies. J Clin Pathol. 1987 Jan;40(1):19–25. [PMC free article] [PubMed]
  • Momburg F, Moldenhauer G, Hämmerling GJ, Möller P. Immunohistochemical study of the expression of a Mr 34,000 human epithelium-specific surface glycoprotein in normal and malignant tissues. Cancer Res. 1987 Jun 1;47(11):2883–2891. [PubMed]
  • Moldenhauer G, Momburg F, Möller P, Schwartz R, Hämmerling GJ. Epithelium-specific surface glycoprotein of Mr 34,000 is a widely distributed human carcinoma marker. Br J Cancer. 1987 Dec;56(6):714–721. [PubMed]
  • Dippold WG, Klingel R, Bernhard H, Dienes HP, Knuth A, Meyer zum Büschenfelde KH. Secretory epithelial cell marker on gastrointestinal tumors and in human secretions defined by a monoclonal antibody. Cancer Res. 1987 Apr 15;47(8):2092–2097. [PubMed]
  • Jones DB, Scott CS, Wright DH, Stein H, Beverley PC, Payne SV, Crawford DH. Phenotypic analysis of an established cell line derived from a patient with Hodgkin's disease (HD). Hematol Oncol. 1985 Apr-Jun;3(2):133–145. [PubMed]
  • Kamesaki H, Fukuhara S, Tatsumi E, Uchino H, Yamabe H, Miwa H, Shirakawa S, Hatanaka M, Honjo T. Cytochemical, immunologic, chromosomal, and molecular genetic analysis of a novel cell line derived from Hodgkin's disease. Blood. 1986 Jul;68(1):285–292. [PubMed]
  • Diehl V, Kirchner HH, Schaadt M, Fonatsch C, Stein H, Gerdes J, Boie C. Hodgkin's disease: establishment and characterization of four in vitro cell lies. J Cancer Res Clin Oncol. 1981;101(1):111–124. [PubMed]
  • Cordell JL, Falini B, Erber WN, Ghosh AK, Abdulaziz Z, MacDonald S, Pulford KA, Stein H, Mason DY. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem. 1984 Feb;32(2):219–229. [PubMed]
  • Stein H, Gatter K, Asbahr H, Mason DY. Use of freeze-dried paraffin-embedded sections for immunohistologic staining with monoclonal antibodies. Lab Invest. 1985 Jun;52(6):676–683. [PubMed]
  • Stein H, Gerdes J, Schwab U, Lemke H, Mason DY, Ziegler A, Schienle W, Diehl V. Identification of Hodgkin and Sternberg-reed cells as a unique cell type derived from a newly-detected small-cell population. Int J Cancer. 1982 Oct 15;30(4):445–459. [PubMed]
  • Köhler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 1975 Aug 7;256(5517):495–497. [PubMed]
  • Thorell JI, Johansson BG. Enzymatic iodination of polypeptides with 125I to high specific activity. Biochim Biophys Acta. 1971 Dec 28;251(3):363–369. [PubMed]
  • Wano Y, Uchiyama T, Fukui K, Maeda M, Uchino H, Yodoi J. Characterization of human interleukin 2 receptor (Tac antigen) in normal and leukemic T cells: co-expression of normal and aberrant receptors on Hut-102 cells. J Immunol. 1984 Jun;132(6):3005–3010. [PubMed]
  • Schwarting R, Stein H, Wang CY. The monoclonal antibodies alpha S-HCL 1 (alpha Leu-14) and alpha S-HCL 3 (alpha Leu-M5) allow the diagnosis of hairy cell leukemia. Blood. 1985 Apr;65(4):974–983. [PubMed]
  • Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. [PubMed]
  • Thotakura NR, Bahl OP. Enzymatic deglycosylation of glycoproteins. Methods Enzymol. 1987;138:350–359. [PubMed]
  • Woodward MP, Young WW, Jr, Bloodgood RA. Detection of monoclonal antibodies specific for carbohydrate epitopes using periodate oxidation. J Immunol Methods. 1985 Apr 8;78(1):143–153. [PubMed]
  • Stefanini M, De Martino C, Zamboni L. Fixation of ejaculated spermatozoa for electron microscopy. Nature. 1967 Oct 14;216(5111):173–174. [PubMed]
  • Cordon-Cardo C, Mattes MJ, Melamed MR, Lewis JL, Jr, Old LJ, Lloyd KO. Immunopathologic analysis of a panel of mouse monoclonal antibodies reacting with human ovarian carcinomas and other human tumors. Int J Gynecol Pathol. 1985;4(2):121–130. [PubMed]
  • Lozzio CB, Lozzio BB. Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood. 1975 Mar;45(3):321–334. [PubMed]
  • Zauli D, Gobbi M, Crespi C, Tazzari PL, Miserocchi F, Magnani M, Testoni N. Vimentin and keratin intermediate filaments expression by K562 leukemic cell line. Leuk Res. 1986;10(1):29–33. [PubMed]
  • van Eyken P, Sciot R, van Damme B, de Wolf-Peeters C, Desmet VJ. Keratin immunohistochemistry in normal human liver. Cytokeratin pattern of hepatocytes, bile ducts and acinar gradient. Virchows Arch A Pathol Anat Histopathol. 1987;412(1):63–72. [PubMed]
  • Warnock ML, Stoloff A, Thor A. Differentiation of adenocarcinoma of the lung from mesothelioma. Periodic acid-Schiff, monoclonal antibodies B72.3, and Leu M1. Am J Pathol. 1988 Oct;133(1):30–38. [PubMed]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Group